The MondoA/Mlx-Txnip metabolic regulation pathway are implicated an substantial role in the occurrence and development of many diseases, such as the first and second most common causes of premature mortality, cancer (Abu el Maaty et al., 2017, 2019) and diabetes (Szpigel et al., 2018). Here, TXNIP is linked to diabetes mellitus.